Jessalyn Ubellacker

18PUBLICATIONS
153CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Mar 14, 2026
Riboflavin metabolism shapes FSP1-driven ferroptosis resistance.

Vera Skafar, Izadora de Souza, Biplab Ghosh

|Feb 18, 2026
GPX4 Inhibitor Resistance and Metastatic Features in Triple-Negative Breast Cancer.

Marie Sabatier, Mayher Kaur, Milena Chaufan

|Dec 25, 2025
Plasma plasmalogen levels and risk of lymph node positive breast cancer.

Mahsa Yavari, Kristen D Brantley, Alanis Carmona

|Nov 05, 2025
Lymph node environment drives FSP1 targetability in metastasizing melanoma.

Mario Palma, Milena Chaufan, Cort B Breuer

|Sep 26, 2025
Overcoming impaired antigen presentation in tumor draining lymph nodes facilitates immunotherapy.

Meghan J O'Melia, Lutz Menzel, Pin-Ji Lei

|Aug 18, 2025
Prospects for ferroptosis therapies in cancer.

Jessalyn M Ubellacker, Scott J Dixon

Pageof 3

Frequent Collaborators

9 joint publications

Marie Sabatier

5 joint publications

Mario Palma

5 joint publications

Cameron S Fraser

4 joint publications

Marcus Conrad